(Q33399333)

English

Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

Georg-Friedrich von Tempelhoff

object named as

Georg-Friedrich von Tempelhoff

6

0 references

Leylagul Kaynar

1 reference

ORCID Public Data File 2021

author name string

Sylvia K Haas

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mathias Freund

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

David Heigener

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lothar Heilmann

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bettina Kemkes-Matthes

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nima Melzer

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ajay K Kakkar

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

TOPIC Investigators

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

23 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical and Applied Thrombosis-Hemostasis

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

159-165

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Management of thrombosis in cancer: primary prevention and secondary prophylaxis

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Prospective evaluation of health-related quality of life in patients with deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Development and validation of a predictive model for chemotherapy-associated thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Predictors of venous thromboembolism in patients with advanced common solid cancers

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Antimetastatic activities of heparins and modified heparins. Experimental evidence.

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1177%2F1076029611433769

21 January 2018

Identifiers

10.1177/1076029611433769

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33399333&oldid=1986078572"